To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Perioperative administration of cyclooxygenase-2 inhibitors reduces pain in TKA patients

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2013

Perioperative administration of cyclooxygenase-2 inhibitors reduces pain in TKA patients

Vol: 2| Issue: 3| Number:115| ISSN#: 2564-2537
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A

Perioperative administration of selective cyclooxygenase-2 inhibitors for postoperative pain management in patients after total knee arthroplasty

J Arthroplasty. 2013 Feb;28(2):207-213.e2. doi: 10.1016/j.arth.2012.04.008. Epub 2012 Jun 7

Contributing Authors:
J Lin L Zhang H Yang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

8 studies (571 patients) were analyzed to evaluate the postoperative effects of selective cyclooxygenase-2 (COX-2) inhibitors when administered to patients during TKA. Results indicated that COX-2 inhibitors administered during TKA resulted in reduced postoperative pain, opioid consumption, and incidence of complications. Blood loss during the first 24 hours following surgery did not differ betwee...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue